Document Detail

The role of DNA microarrays in the evaluation of fetal death.
MedLine Citation:
PMID:  22467168     Owner:  NLM     Status:  In-Data-Review    
Fetal death occurs in 15% of clinically recognized pregnancies. Cytogenetic abnormalities are present in 50% of spontaneous abortions (fetal deaths < 20 weeks) whereas the rate is 6% to 13% for stillbirths (fetal deaths ≥ 20 weeks). Microarray has been demonstrated to increase the diagnosis of genetic abnormalities by providing coverage of the entire genome at a higher density, detecting as small as 50 to 100 kb deletions or duplications, known as copy number changes. Microarray is particularly suited for evaluation of fetal death because DNA can still be analyzed in macerated fetuses and nonviable tissue, two situations where culturing and karyotyping is known to have low yield. Microarray has already proven successful in providing additional genetic information beyond karyotype in spontaneous abortion. The few studies on the use of microarray in stillbirth evaluation have been promising, demonstrating an increase in the diagnosis of clinically relevant genetic abnormalities when compared with karyotype. As the cost and technology improve, microarray may ultimately become the first line screen for genetic abnormalities in stillbirth. The accurate diagnosis of a genetic abnormality as the cause for fetal death may provide closure for families, prevent unnecessary treatments, and enable clinicians to more accurately counsel and manage subsequent pregnancies. © 2012 John Wiley & Sons, Ltd.
Uma M Reddy; Grier P Page; George R Saade
Related Documents :
24591948 - Are pregnancy complications increased in poor responders?
12122428 - Maternal malaria: plasmodium falciparum sequestration in the placenta.
23018478 - Pulmonary embolism in pregnancy. consen-sus and controversies.
19946608 - Implementing intermittent preventive treatment for malaria in pregnancy: review of pros...
20305178 - Ps2-16: excessive gestational weight gain is predictive of postpartum weight retention ...
19646688 - Factors influencing intestinal cadmium uptake in pregnant bangladeshi women--a prospect...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  32     ISSN:  1097-0223     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  371-5     Citation Subset:  IM    
Copyright Information:
© 2012 John Wiley & Sons, Ltd.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Non-targeted whole genome 250K SNP array analysis as replacement for karyotyping in fetuses with str...
Next Document:  Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing.